跳至主要内容
临床试验/NCT05354427
NCT05354427已完成不适用

Evaluation of Commercially Available Implantable Spacers, in Prostate Cancer Patients Undergoing Radiotherapy

BioProtect2 个研究点 分布在 2 个国家目标入组 175 人开始时间: 2020年6月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
BioProtect
入组人数
175
试验地点
2
主要终点
Evaluation of Rectal radiation Dose

研究概览

简要总结

Assessment of efficacy and safety of implantable spacers when used to reduce the radiation dose delivered to the organs at risk in prostate cancer patients undergoing radiotherapy.

详细描述

Multi-center, retrospective, observational study for assessment of rectal dose reduction following implantation of the BioProtect Balloon Implant System

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • - Males at least 18 years of age, who have undergone radiation therapy with implantable spacers

排除标准

  • Patients whose clinical and pathological data are not available.
  • Patients have been histologically diagnosed with invasive adenocarcinoma that is extracapsular with posterior extension

结局指标

主要结局

Evaluation of Rectal radiation Dose

时间窗: 1 month

Dosimetry change to organs at risk in subjects with prostate cancer who have undergone radiotherapy with implantable spacers when compared to pre-implantation values.

次要结局

  • Prostate to rectum spacing(1 month)

研究者

发起方
BioProtect
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Retrospective Evaluation of Commercial Spacers in... | 临床试验